TrialArthritis research & therapy2018

Effect of filgotinib, a selective JAK 1 inhibitor, with and without methotrexate in patients with rheumatoid arthritis: patient-reported outcomes.

Mark Genovese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.